Exosome Effect on Prevention of Hairloss

Last updated: December 17, 2022
Sponsor: Isfahan University of Medical Sciences
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hair Loss

Alopecia

Treatment

N/A

Clinical Study ID

NCT05658094
Isfahan Med Uni
  • Ages 25-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Many people suffer from alopecia, which is caused by hereditary factors, emotional stress, and psychiatric disorders. There are devastating physical and psychological consequences as a result. Exosomes are isolated from donated human amniotic mesenchymal stem cells and purified using specific processing. Exosomes are unique in that they are derived from stem cells and contain a wide range of growth factors. The latest generation of natural products for treating hair loss is exosomes.

Eligibility Criteria

Inclusion

Inclusion Criteria: subjects able to read the documents and have medical coverage Subjects have a "hair loss grade" as below criteria:

  1. BASP grade: Basic type (M2 to M3, or C2 to C3, or U1 to U3) or Specific type (V1 toV3, or F1 to F3)
  2. For female: Ludwig grade: Ⅰ to Ⅱ
  3. For male: Norwood-Hamilton grade: III to IV
  4. Hair density by phototrichogram: 60 to 190 hair/cm2
  5. Telogen hair ≥ 5% Subject agreeing not to apply any topical treatment Subject agreeingto use a neutral shampoo

Exclusion

Exclusion Criteria:

  1. Sick subject in situation of emergency.
  2. Subjects who have hereditary history of hairloss
  3. Pregnant Females
  4. Subject using topic cosmetic treatment or oral nutritional supplement likely tointerfere on hair loss parameters during the last 3 months prior to the start of thestudy (screening)
  5. Subjects who have a medical treatment for alopecia or having stopped it from than 3months

Study Design

Total Participants: 20
Study Start date:
August 01, 2022
Estimated Completion Date:
October 29, 2023

Study Description

Exosomes contain a variety of growth factors that are derived from stem cells. As they are so small, they can be hidden in the bloodstream and carry different types of proteins.

The Wnt-β-catenin pathway is thought to play a major role in the pathogenesis of hair loss. The only FDA-approved medications for the treatment of hair loss are minoxidil (a vasodilator) and finasteride (a selective inhibitor of 5α reductase type II and III isoforms). However, these drugs have not been very perfect. Both have been associated with limited efficacy, duration of effect, and several significant side effects. Regenerative medicine using cell products is looking for a way to heal faster and less cost. Present research focus on Exosome efficacy on hairloss.

Connect with a study center

  • Leila Dehghani

    Isfahan, 8179997781
    Iran, Islamic Republic of

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.